ID   ABL-2
AC   CVCL_D321
DR   CGH-DB; 9188-4
DR   Wikidata; Q54607735
RX   PubMed=3934897;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 32 hours (PubMed=3934897).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 13
//
RX   PubMed=3934897;
RA   Matsuo Y., Motoori T., Irie K., Natori H., Hayashi A., Mizote H.,
RA   Sagawa K., Yokoyama M.M.;
RT   "Establishment and characterization of an interleukin-2 receptor
RT   bearing a Burkitt's lymphoma cell line (ABL-2).";
RL   Nihon Ketsueki Gakkai Zasshi 48:1187-1197(1985).
//